share_log

Yangmei ChemicalLtd (SHSE:600691 Investor Three-year Losses Grow to 46% as the Stock Sheds CN¥428m This Past Week

Yangmei ChemicalLtd (SHSE:600691 Investor Three-year Losses Grow to 46% as the Stock Sheds CN¥428m This Past Week

揚美化工股份有限公司(SHSE:600691)投資者三年內虧損增長46%,該股上週下跌了4.28億元。
Simply Wall St ·  06/17 21:47

For many investors, the main point of stock picking is to generate higher returns than the overall market. But in any portfolio, there are likely to be some stocks that fall short of that benchmark. We regret to report that long term Yangmei Chemical Co.,Ltd (SHSE:600691) shareholders have had that experience, with the share price dropping 46% in three years, versus a market decline of about 22%. And more recent buyers are having a tough time too, with a drop of 40% in the last year. Furthermore, it's down 28% in about a quarter. That's not much fun for holders.

對於許多投資者來說,股票挑選的主要目標是獲得比整個市場更高的回報率。但在任何組合中,都可能有一些股票低於該基準。我們很遺憾地報告,長揸陽煤化工股份有限公司(上海證券交易所:600691)的股東們已經經歷了這種經歷,股價在三年中下降了46%,而市場則下跌了約22%。最近的買家也面臨着困難,去年下跌了40%。此外,它在約一個季度內下跌了28%。這對股東來說並不好玩。

After losing 9.0% this past week, it's worth investigating the company's fundamentals to see what we can infer from past performance.

在過去的一週中下跌了9.0%後,值得調查該公司的基本面,以了解我們可以從過去的表現中推斷出什麼。

Because Yangmei ChemicalLtd made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.

因爲陽煤化工有限公司在過去十二個月內虧損,我們認爲市場可能更加關注營業收入和營業收入的增長,至少目前是這樣。一般來說,沒有利潤的公司被期望每年都能有收入的增長,並以很快的速度增長。這是因爲快速增長的營業收入可以輕易推導出盈利預測,通常規模相當大。

Over the last three years, Yangmei ChemicalLtd's revenue dropped 15% per year. That's definitely a weaker result than most pre-profit companies report. With revenue in decline, the share price decline of 13% per year is hardly undeserved. The key question now is whether the company has the capacity to fund itself to profitability, without more cash. The company will need to return to revenue growth as quickly as possible, if it wants to see some enthusiasm from investors.

在過去的三年裏,陽煤化工有限公司的營業收入每年下降15%。這絕對是比大多數未盈利公司報告的成績更差的。隨着營業收入的下降,每年13%的股價下跌並不是無妄之災。現在的關鍵問題是,該公司是否有能力在沒有更多現金的情況下自己融資至盈利。如果希望從投資者那裏看到一些熱情,該公司需要儘快恢復營業收入的增長。

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

你可以在下面的圖片中看到收入和營業收入隨時間的變化情況(單擊圖表可查看精確值)。

earnings-and-revenue-growth
SHSE:600691 Earnings and Revenue Growth June 18th 2024
SHSE:600691 財務業績和營業收入增長 2024年6月18日

If you are thinking of buying or selling Yangmei ChemicalLtd stock, you should check out this FREE detailed report on its balance sheet.

如果您正在考慮買入或賣出陽煤化工股份有限公司的股票,您應該查看關於其資產負債表的這份免費詳細報告。

A Different Perspective

不同的觀點

While the broader market lost about 15% in the twelve months, Yangmei ChemicalLtd shareholders did even worse, losing 40%. However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 6% per year over five years. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. You might want to assess this data-rich visualization of its earnings, revenue and cash flow.

雖然整個市場在過去的12個月中損失了約15%,但陽煤化工股份有限公司的股東們遭受了更嚴重的損失,下跌了40%。然而,股價受到整個市場的擔憂影響是可能的。如果有好的機會,值得關注其基本面。令人遺憾的是,去年的表現堪稱糟糕,股東在過去五年中每年面臨6%的總虧損。我們意識到巴倫·羅斯柴爾德曾說過投資者應該「在街上有血時買入」,但我們警告投資者首先要確保他們正在購買高質量的企業。您可能需要評估一下它的收益,營收和現金流的這些數據豐富的可視化。

Of course Yangmei ChemicalLtd may not be the best stock to buy. So you may wish to see this free collection of growth stocks.

當然,陽煤化工有限公司可能不是最好的股票買點。所以您可能希望看看這個免費的增長股合集。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或電郵 editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,也可以發送電子郵件至editorial-team@simplywallst.com

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論